Skip to main content
Premium Trial:

Request an Annual Quote

Protagen NavigAid SSc

Progtagen has launched the NavigAid systemic sclerosis (SSc) disease stratification assay for use in drug development.

NavigAid SSc achieves patient stratification by measuring serum biomarkers and has been specifically developed to address heterogeneity in patients with the disease. The assay enables differential diagnosis, risk stratification, and prediction of organ involvement.